Vivos Therapeutics Inc (VVOS)
2.25
-0.20
(-8.16%)
USD |
NASDAQ |
Jun 14, 16:00
2.27
+0.02
(+0.89%)
After-Hours: 20:00
Vivos Therapeutics Revenue (Quarterly): 3.419M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.419M |
| December 31, 2023 | 3.248M |
| September 30, 2023 | 3.301M |
| June 30, 2023 | 3.395M |
| March 31, 2023 | 3.857M |
| December 31, 2022 | 3.95M |
| September 30, 2022 | 4.246M |
| June 30, 2022 | 4.184M |
| March 31, 2022 | 3.644M |
| December 31, 2021 | 4.394M |
| Date | Value |
|---|---|
| September 30, 2021 | 4.546M |
| June 30, 2021 | 4.497M |
| March 31, 2021 | 3.448M |
| December 31, 2020 | 3.307M |
| September 30, 2020 | 3.292M |
| June 30, 2020 | 3.271M |
| March 31, 2020 | 3.196M |
| December 31, 2019 | 3.056M |
| September 30, 2019 | 3.316M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.056M
Minimum
Dec 2019
4.546M
Maximum
Sep 2021
3.661M
Average
3.419M
Median
Mar 2024
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 13.87M |
| Xtant Medical Holdings Inc | 27.87M |
| Asensus Surgical Inc | 1.123M |
| Senseonics Holdings Inc | 5.047M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.763M |
| Total Expenses (Quarterly) | 7.204M |
| EPS Diluted (Quarterly) | -1.63 |
| Enterprise Value | 4.650M |
| Gross Profit Margin (Quarterly) | 56.65% |
| Profit Margin (Quarterly) | -110.1% |
| Earnings Yield | -485.8% |
| Normalized Earnings Yield | -508.01 |